Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling and Documenting Storage Deviations and Non-Conformances – V 2.0

Posted on By

SOP for Handling and Documenting Storage Deviations and Non-Conformances – V 2.0

Standard Operating Procedure for Handling and Documenting Storage Deviations and Non-Conformances

Department Quality Assurance / Warehouse
SOP No. SOP/RM/167/2025
Supersedes SOP/RM/167/2022
Page No. Page 1 of 14
Issue Date 03/04/2025
Effective Date 10/04/2025
Review Date 03/04/2026

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for identifying, handling, and documenting storage deviations and non-conformances in raw material warehouses. It ensures systematic management of any deviation from standard storage conditions, maintaining compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all storage areas, including ambient, refrigerated, and controlled environments, where raw materials are stored. It covers the identification, documentation, investigation, and resolution of storage deviations and non-conformances.

3. Responsibilities

  • Warehouse Personnel: Identify and report storage deviations or non-conformances immediately. Assist in investigations as required.
  • Warehouse Supervisor: Review reported deviations, initiate investigations, and coordinate with QA for resolution.
  • Quality Assurance (QA): Oversee deviation investigations, ensure proper documentation, and verify the implementation of corrective and preventive actions.

4. Accountability

The QA Manager is accountable for ensuring all storage deviations are documented and resolved appropriately. The Warehouse Manager is responsible for the timely reporting and management of deviations.

5. Procedure

5.1 Identification and Reporting of Deviations

  1. Definition of Deviation:
    • A deviation is any departure from the established storage conditions, procedures, or standards. Examples include temperature excursions, humidity fluctuations, improper labeling, or unauthorized access to storage areas.
  2. Reporting Process:
    • Warehouse personnel must immediately report observed deviations to the Warehouse Supervisor using the Deviation Reporting Form (Annexure-1).
    • The Warehouse Supervisor must notify the QA department within 2 hours of identifying the deviation.
See also  SOP for Ensuring GMP Compliance in Raw Material Storage - V 2.0

5.2 Initial Assessment and Immediate Actions

  1. Immediate Control Measures:
    • Take immediate actions to control or mitigate the impact of the deviation, such as relocating affected materials to compliant storage or adjusting environmental controls.
    • Document immediate actions taken in the Deviation Immediate Action Log (Annexure-2).
  2. Initial Assessment:
    • The Warehouse Supervisor, in consultation with QA, will perform an initial assessment to determine the potential impact on material quality.
    • If materials are suspected to be compromised, quarantine them until further investigation is complete.

5.3 Investigation and Root Cause Analysis

  1. Investigation Process:
    • The QA department will initiate a detailed investigation to determine the root cause of the deviation within 24 hours of reporting.
    • Use tools such as the 5 Whys or Fishbone Diagram to identify root causes.
    • Document the investigation in the Deviation Investigation Report (Annexure-3).
  2. Classification of Deviations:
    • Classify deviations as minor, major, or critical based on their potential impact on product quality and patient safety.
    • Record the classification in the Deviation Classification Log (Annexure-4).
See also  SOP for Managing Temperature-Controlled Zones in Warehouses - V 2.0

5.4 Corrective and Preventive Actions (CAPA)

  1. Corrective Actions:
    • Implement corrective actions to address the immediate cause of the deviation and prevent recurrence.
    • Document corrective actions in the Corrective Action Log (Annexure-5).
  2. Preventive Actions:
    • Develop preventive measures to eliminate systemic issues contributing to deviations, such as process changes or additional training.
    • Document preventive actions in the Preventive Action Log (Annexure-6).

5.5 Deviation Closure and Documentation

  1. Final Review and Approval:
    • The QA department will review all documentation and verify the effectiveness of corrective and preventive actions before closing the deviation.
    • Document the closure in the Deviation Closure Log (Annexure-7).
  2. Archiving Records:
    • All deviation records must be securely stored and accessible for regulatory inspections and internal audits.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Deviation Reporting Form (Annexure-1)
  2. Deviation Immediate Action Log (Annexure-2)
  3. Deviation Investigation Report (Annexure-3)
  4. Deviation Classification Log (Annexure-4)
  5. Corrective Action Log (Annexure-5)
  6. Preventive Action Log (Annexure-6)
  7. Deviation Closure Log (Annexure-7)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
  • WHO Guidelines on Good Manufacturing Practices for Pharmaceutical Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department
See also  SOP for Controlled Storage of Radioactive or Hazardous Raw Materials - V 2.0

Annexure-1: Deviation Reporting Form

Date Deviation Description Reported By Storage Area
03/04/2025 Temperature excursion in cold storage Ravi Kumar Cold Storage Unit

Annexure-2: Deviation Immediate Action Log

Date Action Taken Performed By Remarks
03/04/2025 Adjusted thermostat and relocated materials Neha Verma Materials moved to compliant storage

Annexure-3: Deviation Investigation Report

Date Investigation Findings Root Cause Investigated By
04/04/2025 Thermostat malfunction due to electrical issue Faulty wiring in cooling unit Amit Joshi

Annexure-4: Deviation Classification Log

Date Deviation Description Severity Classified By
04/04/2025 Temperature excursion in cold storage Major QA Manager

Annexure-5: Corrective Action Log

Date Corrective Action Performed By Verified By
05/04/2025 Replaced faulty thermostat and repaired wiring Maintenance Team QA Team

Annexure-6: Preventive Action Log

Date Preventive Action Reason Implemented By
06/04/2025 Installed backup temperature monitoring system Prevent future excursions Ravi Kumar

Annexure-7: Deviation Closure Log

Date Deviation Description Closure Status Approved By
07/04/2025 Temperature excursion in cold storage Closed QA Manager

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Implementation QA Head
03/04/2025 2.0 Added CAPA Documentation Requirements Regulatory Compliance Update QA Head
Raw Material Warehouse V 2.0 Tags:Audit compliance in material storage, Contamination prevention in warehouses, Documentation in warehouse operations, Emergency procedures in warehouses, Equipment maintenance in warehouses, FIFO method in inventory, Handling of hazardous materials, Inventory management SOP, Labeling requirements in warehouses, Loading and unloading procedures, Material inspection protocol, Material receiving process, Material segregation guidelines, Pest control in storage areas, Quality control in warehousing, Raw material handling SOP, Return material handling SOP, Safety procedures for material handling, Security measures for stored materials, Spill response procedures, Storage conditions for raw materials, Temperature and humidity control in storage, Training for warehouse personnel, Warehouse storage procedures, Waste management in warehouses

Post navigation

Previous Post: Capsule: SOP for Validation of In-Process Testing for Capsules – V 2.0
Next Post: Capsule: SOP for Visual Inspection of Capsule Shells – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version